跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FORTASEC FLAS 2 MG LIOFILIZADO ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
FORTASEC FLAS 2 MG LIOFILIZADO ORAL
Approved
STANDARD
FORTASEC FLAS 2 MG LIOFILIZADO ORAL
Mcneil Healthcare (Ireland) Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jul 9, 2025
Approval ID
e8e3a20e4c34748e
Company
Mcneil Healthcare (Ireland) Limited
Type
Standard
Approval Details
Approval Id
e8e3a20e4c34748e
Drug Cima Aemps Name
FORTASEC FLAS 2 MG LIOFILIZADO ORAL
Register Number
9091
Holder Company Name
Mcneil Healthcare (Ireland) Limited
Marketing Company Name
Difarmed S.L.U.
Authorization Date
2025-07-09
Dosage Form
LIOFILIZADO ORAL
Dose
2 mg
Route Of Administration
VÍA ORAL
Prescription Type
Sin Receta
Commercialized
No
Company Name
Mcneil Healthcare (Ireland) Limited
Active Ingredients
LOPERAMIDA
2 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jul 9, 2025
Approval ID
e8e3a20e4c34748e
Type
Standard
Back to CIMA-AEMPS Approvals